Projects Details as Principal Investigator/Co-Investigator (completed)
Synthesis and pharmacological evaluation of novel phosphodiesterase 4 inhibitors for their anti-depressant and anxiolytic potential (DBT, Rs. 51.69 Lakhs; three years, Completed March 2013)
Novel Neuro-Pharmacological Agents for the Treatment of Depression, Anxiety, Cognitive Dysfunction and CCIE: Design, Synthesis and Screening of Potential Serotonergic Modulators (ICMR, Rs. 31.20 Lakhs; 3 years, Completed Dec 2013)
International malarial research consortium for the development of novel classes of antimalarials, Indo-Canadian DBT Project (Indo-Canadian Joint Research Consortium on Anti-Malarials; DBT ; Rs, 35.50 Lakhs; three years, Phase-I; Completed Sept 2013)
International malarial research consortium for the development of novel classes of antimalarials, Indo-Canadian DBT Project (Indo-Canadian Joint Research Consortium on Anti-Malarials; DBT ; Rs, 21.86 Lakhs; two years, Phase-II; Completed FY 2016-17)
Infrastructural development of the department (level II) (UGC Rs. 72 Lakhs; five years)- Deputy Co-ordinator.
Design and Synthesis of Novel Agents for the Management of Rheumatoid Arthritis, (UGC, 2010-13, 11.98 Lakhs, three years, Completed August 2013), Co-Investigator.
Novel Quinoxaline carboxamides: Design, Synthesis and Neuro-Pharmacological Evaluation as Antidepressants, Anxiolytics, and in the management of Cancer Chemotherapy induced Nausea and Vomiting, UGC, Rs. 8.476 lakhs, 2007-2010, Principal Investigator.
Besides the above, few minor research projects have been completed in the past.
As head of the Department, was instrumental in submitted proposals for upgrading Departmental infrastructure for research and academics through UGC –DRS-SAP Level I and II, DST –FIST Level I and II. Funds received have been utilized for enhancing research equipments assets. Pharmacy laboratories were upgraded with additional funds of Rs. 40.00 lakhs obtained from UGC for infrastructural development over 2 years